Limba
Romanian
Romanian
English|
lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262), 1mg
1.973,02 RON
SKU
SKM_A2330_1mg
Lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. MW : 145.5 KD.
| Price | 1.658,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. MW : 145.5 KD. |
